Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Separation, concentration, and transfusion of platelets.Proc Soc Exp Biol Med. 1951; 78: 796-799
- Effect of storage temperature on maintenance of platelet viability—deleterious effect of refrigerated storage.N Engl J Med. 1969; 280: 1094-1098
Lee J-H. Bacterial Contamination of Platelets Workshop. U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research. Bethesda (MD), September 24, 1999. p. 70–83.
- Bacterial detection of platelets: current problems and possible resolutions.Transfus Med Rev. 2005; 19: 259-272
- Platelet storage at 22 degrees C; metabolic, morphologic, and functional studies.J Clin Invest. 1971; 50: 370-377
- The collection of platelets by apheresis procedures.Transfus Med Rev. 1994; 8: 132-145
- White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasma.Transfusion. 1995; 35: 131-136
- Platelets from pooled buffy coats: an update.Transfusion. 2005; 45: 634-639
- A critical comparison of platelet preparation methods.Curr Opin Hematol. 2006; 13: 323-330
- Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.Transfusion. 2008; 48: 2331-2337
- Evaluation of stored platelets.Vox Sang. 2004; 86: 203-223
- Quantitation of CD62, soluble CD62, and lysosome-associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates.Transfusion. 1995; 35: 292-297
- Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy.Eur J Haematol. 1995; 55: 145-151
- Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vitro.Blood. 1981; 57: 199-202
- A study of variables affecting the quality of platelets stored at “room temperature”.Transfusion. 1975; 15: 414-421
- The platelet response to hypotonic shock. Its value as an indicator of platelet viability after storage.Transfusion. 1974; 14: 130-138
- Quantitative measurements of platelet shape by light transmission studies; application to storage of platelets for transfusion.J Lab Clin Med. 1978; 92: 53-64
- Storage of platelet concentrates at 22°C.Blood. 1970; 35: 549-557
- The mechanism of apoptosis in human platelets during storage.Transfusion. 2000; 40: 1320-1329
- Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies.Transfusion. 2009; 49: 2276-2284
- Portable dynamic light scattering instrument and method for the measurement of blood platelet suspensions.Phys Med Biol. 2006; 51: 3747-3758
- Guide to the preparation, use, and quality assurance of blood components.13th edition. Council of Europe Publishing, Strasbourg (France)2007
- Suitability of measurement of swirling as a marker of platelet shape change in concentrates stored for transfusion.Platelets. 2006; 17: 393-396
- The absence of swirling in platelet concentrates is highly predictive of poor posttransfusion platelet count increments and increased risk of a transfusion reaction.Transfusion. 2000; 40: 121-122
- Concurrent label method with 111In and 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates.Br J Haematol. 1993; 84: 717-723
- In vitro assessment of the quality of stored platelet concentrates.Transfus Med Rev. 1994; 8: 29-36
- Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects.Vox Sang. 2006; 90: 279-285
- Improved storage of platelets for transfusion in a new container.Blood. 1982; 60: 194-200
- Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution.Br J Haematol. 1987; 66: 233-238
- Development of a combined storage medium for 7-day storage of platelet concentrates.Br J Haematol. 1990; 75: 400-407
- Effect on platelet properties of exposure to temperatures below 20°C for short periods during storage at 20 to 24°C.Transfusion. 1994; 34: 317-321
- The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability.Transfusion. 1997; 37: 12-17
- Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion.Transfusion. 1991; 31: 409-414
- Detection and significance of alpha granule membrane protein 140 expression on platelets collected by apheresis.Transfusion. 1992; 32: 529-533
- Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study.Transfusion. 2002; 42: 847-854
- Improved maintenance of platelet in vivo viability during storage when using a synthetic medium with inhibitors.J Lab Clin Med. 1992; 119: 144-150
- The clearance mechanism of chilled blood platelets.Cell. 2003; 112: 87-97
- In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.Proc Natl Acad Sci U S A. 1996; 93: 11877-11882
- In vitro assays used in the evaluation of the quality of stored platelets: correlation with in vivo assays.Transfus Apheresis Sci. 2008; 39: 161-165
- In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.Transfusion. 2006; 46: 257-264
- Storage and quality assessment of platelets.Vox Sang. 1998; 74: 207-216
- Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival.Transfusion. 2003; 43: 1230-1237
- Restoration of in vitro responses in platelets stored in plasma.Am J Clin Pathol. 1999; 111: 693-699
- Assessment of the correlation of platelet morphology with in vivo recovery and survival.Transfusion. 2005; 45: 72S-80S
- Recommended methods for conducting radiolabeled platelet survival studies.Transfusion. 1986; 26: 37-42
- Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review.Transfusion. 2008; 48: 1447-1458
- Effect of extending the platelet storage time on platelet utilization: predictions from a mathematical model of prophylactic platelet support.Transfus Med. 2007; 17: 119-127
- Small-molecule complement inhibitors cannot prevent the development of the platelet storage lesion.Transfusion. 2008; 48: 706-714
- Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage.Transfusion. 1990; 30: 20-25
- Translation of glycoprotein IIIa in stored blood platelets.Transfusion. 2007; 47: 2260-2270
- Profiling of alterations in platelet proteins during storage of platelet concentrates.Transfusion. 2007; 47: 1221-1233
- Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches.Transfusion. 2008; 48: 425-435
- Proteomics meets blood banking: Identification of protein targets for the improvement of platelet quality.J Proteomics. 2010; 73: 436-444
- Platelet additive solutions: a future perspective.Transfus Clin Biol. 2007; 14: 522-525
- Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.Transfus Clin Biol. 2009; 16: 70-74
- Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.Transfusion. 2004; 44: 1204-1211
- A randomized study of buffy coat platelets in platelet additive solution stored 1–5 versus 6–7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.Vox Sang. 2009; 97: 254-259
- In vitro and in vivo effects of potassium and magnesium on storage up to 7 days of apheresis platelet concentrates in platelet additive solution.Vox Sang. 2008; 94: 96-102
- Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.Transfusion. 2008; 48: 847-856
- Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.Transfusion. 1997; 37: 423-435
- Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.Transfusion. 2004; 44: 877-885
- Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.Transfusion. 2009; 49: 1956-1963
- Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial.Blood. 2004; 104: 1534-1541
- Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.Transfusion. 2005; 45: 1335-1341
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
